Summary

The product Anavar 50 mg, manufactured by MuscleCandy, was tested to verify its potency and authenticity. The sample, identified by batch number Lot1011, was submitted by the manufacturer labs@musclecandy.net and analyzed by Janoshik Analytical. The analysis revealed an Oxandrolone concentration of 51.87 mg per tablet, slightly exceeding the labeled claim of 50 mg by 3.74%.

The testing process began on 19 July 2024, with the sample received on 29 July 2024, and analysis completed on 5 August 2024. The results demonstrate close alignment with the label claim, underscoring the product’s reliability. However, independent verification across multiple batches remains recommended to confirm manufacturing consistency.


Detailed Report

Product Overview

Sample Acquisition and Testing

Testing Results


Verification Details


Evaluation of Manufacturer-Submitted Testing

The measured concentration of Oxandrolone aligns closely with the label claim, reflecting a well-controlled manufacturing process. While the results are promising, caution is advised as the data represents a single batch. Additional independent tests are recommended to validate the consistency and accuracy of future production runs.


Conclusion

The analysis confirms that the tested batch of Anavar 50 mg contains 51.87 mg of Oxandrolone per tablet, demonstrating an accuracy of 103.74% relative to the label claim. This minor variance supports the product’s reliability while emphasizing the importance of ongoing independent testing to ensure quality assurance across batches.


Disclaimer

This report is intended for educational and harm-reduction purposes. Reseller-submitted testing can provide valuable insights but may reflect selective sampling. Consumers are encouraged to make informed decisions and consider further independent analysis.